|
1
|
Chen R, Cohen AL and Colman H: Targeted
therapeutics in patients with high-grade gliomas: past, present,
and future. Curr Treat Options Oncol. 17:422016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levin VA, Tonge PJ, Gallo JM, Birtwistle
MR, Dar AC, Iavarone A, Paddison PJ, Heffron TP, Elmquist WF,
Lachowicz JE, et al: CNS Anticancer Drug Discovery and Development
Conference White Paper. Neuro oncol. 17 Suppl 6:vi1–vi26. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taal W, Bromberg JE and van den Bent MJ:
Chemotherapy in glioma. CNS Oncol. 4:179–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu Z and Hunter T: Prolyl isomerase Pin1
in cancer. Cell Res. 24:1033–1049. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
La Montagna R, Caligiuri I, Giordano A and
Rizzolio F: Pin1 and nuclear receptors: A new language? J Cell
Physiol. 228:1799–1801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Atkinson GP, Nozell SE, Harrison DK,
Stonecypher MS, Chen D and Benveniste EN: The prolyl isomerase Pin1
regulates the NF-kappaB signaling pathway and interleukin-8
expression in glioblastoma. Oncogene. 28:3735–3745. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Y, Niu CS and Cheng CD: Pin1-Nanog
expression in human glioma is correlated with advanced tumor
progression. Oncol Rep. 30:560–566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Costantino S, Paneni F, Lüscher TF and
Cosentino F: Pin1 inhibitor Juglone prevents diabetic vascular
dysfunction. Int J Cardiol. 203:702–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wahedi HM, Park YU, Moon EY and Kim SY:
Juglone ameliorates skin wound healing by promoting skin cell
migration through Rac1/Cdc42/PAK pathway. Wound Repair Regen.
24:786–794. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Cheng Y, Wu R, Jiang D, Bai B, Tan
D, Yan T, Sun X, Zhang Q and Wu Z: Antibacterial activity of
Juglone against Staphylococcus aureus: From apparent to
proteomic. Int J Mol Sci. 17:pii: E965. doi:
10.3390/ijms17060965.
|
|
11
|
Hu YG, Shen YF and Li Y: Effect of Pin1
inhibitor juglone on proliferation, migration and angiogenic
ability of breast cancer cell line MCF7Adr. J Huazhong Univ Sci
Technolog Med Sci. 35:531–534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanaoka R, Kushiyama A, Seno Y, Nakatsu Y,
Matsunaga Y, Fukushima T, Tsuchiya Y, Sakoda H, Fujishiro M,
Yamamotoya T, et al: Pin1 inhibitor juglone exerts anti-oncogenic
effects on LNCaP and DU145 cells despite the patterns of gene
regulation by Pin1 differing between these cell lines. PLoS One.
10:e01274672015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schnoor R, Maas SL and Broekman ML:
Heparin in malignant glioma: Review of preclinical studies and
clinical results. J Neurooncol. 124:151–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le Rhun E and Perry JR: Vascular
complications in glioma patients. Handb Clin Neurol. 134:251–266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu J, Cai X, He J, Zhao W, Wang Q and Liu
B: Microarray-based analysis of gene regulation by transcription
factors and microRNAs in glioma. Neurol Sci. 34:1283–1289. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han J, Alvarez-Breckenridge CA, Wang QE
and Yu J: TGF-β signaling and its targeting for glioma treatment.
Am J Cancer Res. 5:945–955. 2015.PubMed/NCBI
|
|
17
|
Yang JW, Hien TT, Lim SC, Jun DW, Choi HS,
Yoon JH, Cho IJ and Kang KW: Pin1 induction in the fibrotic liver
and its roles in TGF-β1 expression and Smad2/3 phosphorylation. J
Hepatol. 60:1235–1241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen ZJ, Esnault S, Rosenthal LA, Szakaly
RJ, Sorkness RL, Westmark PR, Sandor M and Malter JS: Pin1
regulates TGF-beta1 production by activated human and murine
eosinophils and contributes to allergic lung fibrosis. J Clin
Invest. 118:479–490. 2008.PubMed/NCBI
|
|
19
|
Davis BN, Hilyard AC, Lagna G and Hata A:
SMAD proteins control DROSHA-mediated microRNA maturation. Nature.
454:56–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zavadil J, Narasimhan M, Blumenberg M and
Schneider RJ: Transforming growth factor-beta and microRNA:mRNA
regulatory networks in epithelial plasticity. Cells Tissues Organs.
185:157–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang F, Qin Y, Qi L, Fang Q, Zhao L, Chen
S, Li Q, Zhang D and Wang L: Juglone exerts antitumor effect in
ovarian cancer cells. Iran J Basic Med Sci. 18:544–548.
2015.PubMed/NCBI
|
|
22
|
Avcı E, Arıkoğlu H and Kaya Erkoç D:
Investigation of juglone effects on metastasis and angiogenesis in
pancreatic cancer cells. Gene. 588:74–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jha BK, Jung HJ, Seo I, Suh SI, Suh MH and
Baek WK: Juglone induces cell death of Acanthamoeba through
increased production of reactive oxygen species. Exp Parasitol.
159:100–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Atabay KD, Yildiz MT, Avsar T, Karabay A
and Kiliç T: Knockdown of Pin1 leads to reduced angiogenic
potential and tumorigenicity in glioblastoma cells. Oncol Lett.
10:2385–2389. 2015.PubMed/NCBI
|
|
25
|
Ryo A, Hirai A, Nishi M, Liou YC, Perrem
K, Lin SC, Hirano H, Lee SW and Aoki I: A suppressive role of the
prolyl isomerase Pin1 in cellular apoptosis mediated by the
death-associated protein Daxx. J Biol Chem. 282:36671–36681. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paulsen MT and Ljungman M: The natural
toxin juglone causes degradation of p53 and induces rapid H2AX
phosphorylation and cell death in human fibroblasts. Toxicol Appl
Pharmacol. 209:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Calabrò S, Alzoubi K, Bissinger R, Jilani
K, Faggio C and Lang F: Enhanced eryptosis following juglone
exposure. Basic Clin Pharmacol Toxicol. 116:460–467. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu X, Liang E, Song X, Du Z, Zhang Y and
Zhao Y: Inhibition of Pin1 alleviates myocardial fibrosis and
dysfunction in STZ-induced diabetic mice. Biochem Biophys Res
Commun. 479:109–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu M, Yu P, Jiang H, Yang X, Zhao J, Zou
Y and Ge J: The essential role of Pin1 via NF-kappaB signaling in
vascular inflammation and atherosclerosis in ApoE−/−
mice. Int J Mol Sci. 18:6442017. View Article : Google Scholar :
|
|
30
|
Reese S, Vidyasagar A, Jacobson L, Acun Z,
Esnault S, Hullett D, Malter JS and Djamali A: The Pin 1 inhibitor
juglone attenuates kidney fibrogenesis via Pin 1-independent
mechanisms in the unilateral ureteral occlusion model. Fibrogenesis
Tissue Repair. 3:12010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang G, Wang JJ, Tang HM and To SS:
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. Arch
Biochem Biophys. 580:64–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hermansen SK, Nielsen BS, Aaberg-Jessen C
and Kristensen BW: miR-21 is linked to glioma angiogenesis: A
co-localization study. J Histochem Cytochem. 64:138–148. 2016.
View Article : Google Scholar : PubMed/NCBI
|
